© Reuters. Elevance Health earnings beat by $0.54, revenue fell short of estimates
Investing.com – Elevance Health (NYSE: ) reported third quarter EPS of $8.99, $0.54 better than the analyst estimate of $8.45. Revenue for the quarter came in at $42.48B versus the consensus estimate of $42.76B.
Elevance Health’s stock price closed at $465.65. It is down -2.16% in the last 3 months and down -4.54% in the last 12 months.
Elevance Health saw 9 positive EPS revisions and 8 negative EPS revisions in the last 90 days. See Elevance Health’s stock price’s past reactions to earnings here.
According to InvestingPro, Elevance Health’s Financial Health score is “great performance”.
Check out Elevance Health’s , and Elevance Health’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar